WuXi Chemistry’s Post

Latest Update on Evonik’s Distributor Meeting ✨ We were delighted to host over 30 delegates from the European distribution partners of the Active Ingredients and Cosmetic Solutions product lines. This gathering marked our first meeting of its kind since 2019, showcasing the resilience and adaptability of our industry in these unprecedented times. Key topics discussed: Recent corporate acquisitions and how they've reshaped our business line since our last gathering 🔄 An in-depth dialogue with our experts regarding current and upcoming product launches 🚀 Exchange of insights on critical issues concerning Supply Chain, Regulatory, and Sustainability sectors to ensure continued supply and compliance 🌱 Collaborative focus on products that should dominate our joint efforts in the upcoming period 🔍 Our partners left the meeting equipped with the necessary information to succeed in their respective markets in unison with our objectives. Collaboration and expertise lead the way for our continued success. Together, #Innovation, #Sustainability, and #Partnership are more than just concepts—they're the pillars of our collective identity and purpose. #PersonalCare #SpecialityChemicals #ChemicalIndustryExcellence

💡 Navigating the Future of QC: My Key Insights from the QC Lab Exchange in Madrid 🎁   Reflecting on the recent St. Gallen QC Lab Exchange at Moderna in Madrid, I'm excited to share my key takeaways from the insightful and amazingly open discussions during this cross-company exchange on the QC lab topics "Planning Concepts", "Organizational Set-up" and "Value of QC":   📱 1. Digitalization Efforts: Everyone agreed on the importance of transparent and standardized processes as a prerequisite for all digitalization efforts. Traditional approaches need reevaluation to fit the rapidly changing (IT) environment. A holistic digitalization strategy with end-to-end oversight is essential for success. 🎯 2. KPIs for QC Management: There's no one-size-fits-all answer to the best KPIs for QC management. The discussions on input and output KPIs were enlightening, emphasizing the need for KPIs that help us recognize trends early and empower QC employees to take preventive action. 🌍 3. Network and Collaboration Management: In a growingly complex environment, network and collaboration management is crucial to drive and maintain standardization. Standardization significantly lowers the barriers to improvement, simplification, digitalization, automation, and innovation. 🤝 4. QC and Supply Chain Alignment: The partnership and strategy alignment of QC with Supply Chain is a huge opportunity for improvement across the Pharma industry. For instance, while QC might strive for efficiency, the global planning approach might prioritize robust supply and fast time to market. One thought-provoking question that sparked a lot of discussion was: 🔥 "Would you keep your QC if it wasn't a regulatory requirement?" Thanks to Sören Swyter for initiating this conversation.   I'd love to hear your thoughts and opinions. Which of these key takeaways resonates the most with you? Let's continue the conversation in the comments.   #PharmaIndustry #QualityControl #Collaboration #Innovation #LeanLab

"We navigate new and interesting technical and business challenges every day, and people consistently lead with their passion for patients and the science." As one of the pharma industry's most reputed global supply chain leaders, Kimberly L. Foster ('94) thrives on opportunities to help patients worldwide. At Johnson & Johnson, she leads a team responsible for planning, sourcing, and manufacturing advanced therapies and delivering them to patients in a controlled and consistent way -- no small task in an era of supply chain headwinds, geopolitical tensions, and ever-accelerating costs. Read more in our magazine: https://lnkd.in/gx_BTa_u

Excellent interview with our CTO, Dr. Beate Mueller-Tiemann! It's short, but gives great insight into Dr. Mueller-Tiemann's motivation behind our work and areas we can improve. Touching on R&D collaberation with our biggest customers to meet their needs, as well as our industry's shift toward more agile manufacturing solutions due to supply chain constraints, certainly worth a listen! Listen here: https://lnkd.in/ex_m5SEG

“🔵 What makes Hexis truly unique? 🔵 In an increasingly globalized market, Hexis stands out as one of the very few companies in the world that produces entirely in its home country! 🇫🇷 This means: ✔️ Quality and control over every step of the production process. ✔️ Continuous innovation thanks to in-house laboratories. ✔️ Support for the local community and trust in local values. Still have doubts? Watch this video to discover why choosing Hexis means choosing a product of excellence, made with passion and professionalism! 💡” HEXIS S.A.S. HEXIS ITALIA S.R.L. 🎥 Watch the video here: 👇👇👇

📈🏗️🤝 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 & 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐂𝐌𝐎 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲🤝🏗️📈 CMO ROW here with a very exciting news update from the Med Device CMO space, to take us into the memorial day, long weekend ahead! ⭐ DuPont split into 3 independent, publicly traded companies DuPont carries over 220 years of heritage becoming a key manufacturing and chemical organisation. with revenues $12billion+. DuPont recently made the huge acquisition of Spectrum Plastics Group, A DuPont Business within our industry. The organisations will separate into 'Water', 'Electronics' and 'New DuPont'. The latter consisting of industrial solutions along with healthcare. Ed Breen (Executive Chairman & CEO) says, "This is an extraordinary opportunity to deliver long-term, sustainable shareholder value through the creation of three strong, industry-leading companies." ⭐ Cadence, Inc. open Costa Rica facility Cadence have continued their great growth and have now opened a low cost manufacturing facility in Costa Rica, to join a variety of other companies who have a base in the country. Rob Werge (President & CEO) says, “Costa Rica offers a strategic location, a talented workforce, and a sustainable environment, making it the ideal destination for expanding our operations outside of the United States” ⭐ LISI MEDICAL break ground on the expansion of their Big Lake, MN facility LISI Medical are expanding the facility by 45,000ft and will now have a total facility size of 152,000ft at the site upon completion. The total expansion cost is approximately $11 million and will create approximately 30 jobs over the next two years. 🤝 Best of luck to all involved, looking forward to seeing your continued growth across this year! ❓Did I miss anything? - let me know in the comments❓ If you're looking to hire CMO-experienced talent, please reach out as it would be good to learn more on your plans! 📞 +44 775-455-8706 / +1 929-294-7260 📩 [email protected] #medicaldevices #medicaldevicemanufacturing #cmo #contractmanufacturing #expansion #growth

Pharmaceutical engineering has traditionally focused on commercial production. However, evolving product portfolios, shorter market launch times, and high-cost pressures now require earlier and more intensive collaboration throughout the product lifecycle. Fette Compacting supports users right from the research and development stage. Our management team—Joachim Dittrich (CEO), Anke Fischer (CFO), Dr. Marten Klukkert (VP Customer Development Center), and Dr. Martin Schöler (VP Technology)—shares insights into this extended partnership. 🚀 Discover more about our comprehensive solutions and streamline your production process. From Lab to Production, we’re with you every step of the way 💡 🔗 Read the full article here: https://lnkd.in/e-H9NNi5 #FetteCompacting #FetteCompactingIndia #Pharmaceuticals #ProcessDevelopment #Innovation #ContinuousManufacturing #QEDDatabase #FromLabToProduction #LabServices #LabSolutions #ProcessConsultancy

🌍 Pharma Manufacturing Europe in Berlin – Excited for insights on Innovation & Capex Management! 💊 Looking forward to the next two days, gaining valuable insights into the future of the pharma industry and expanding my network with experts from across Europe. I’m particularly excited to moderate a World Café Session on Global Capex Management. 💼💡 Capex strategies are key to optimizing investments and driving sustainable growth – crucial topics shaping the future of pharma manufacturing. Who else is attending? Let’s connect for inspiring conversations and valuable takeaways! 🚀 #PharmaManufacturing #CapexManagement #Innovation #Networking #Conference #Berlin

Things are moving quickly at Remark Filtration Group! 👇 From new developments to global expansion, here’s a snapshot of our journey so far. Exciting times ahead! 🚀 #RemarkGroup #FiltrationInnovation #GlobalExpansion

💡 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘂𝗽𝗽𝗹𝘆 𝗖𝗵𝗮𝗶𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 Landry Giardina, Sanofi’s Global Head of Clinical Supply Chain Operations Innovation & Technology talks data-driven performance, resilience, agility and operational excellence within the clinical supply chain area. Sanofi has a mission: to chase the miracles of science to improve people’s lives, and sometimes that means starting over with Plan B, Plan C, or even Plan Z. To do so means to work across the most complex disciplines to solve problems, to push the boundaries and not be afraid to take smart risks, and to dedicate everything to making life better for people everywhere. Learn more, here https://lnkd.in/eZ8GKg6e 🤝 N-SIDE, Suvoda #supplychain #innovation